Updated efficacy/safety data from the phase 2 NP28761 study of alectinib in ALK plus NSCLC Meeting Abstract
| Authors: | Shaw, A.; West, H.; Socinski, M. A.; Ou, I.; Gandhi, L.; Gadgeel, S.; Belani, C. P.; Shirai, K.; Bazhenova, L.; Santos, E.; Riely, G. J.; Chiappori, A.; Cetnar, J.; Mekhail, T.; Chao, B.; Borghaei, H.; Gold, K. A.; Johannsdottir, H.; Ruf, T.; Boisserie, F.; Henschel, V.; Zeaiter, A.; Camidge, R. |
| Abstract Title: | Updated efficacy/safety data from the phase 2 NP28761 study of alectinib in ALK plus NSCLC |
| Meeting Title: | 16th World Conference on Lung Cancer (WCLC) |
| Keywords: | alk; nsclc; alectinib |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 10 |
| Issue: | 9 Suppl. 2 |
| Meeting Dates: | 2015 Sep 6-9 |
| Meeting Location: | Denver, CO |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-09-01 |
| Start Page: | S237 |
| End Page: | S238 |
| Language: | English |
| ACCESSION: | WOS:000370365100399 |
| PROVIDER: | wos |
| PUBMED: | 26710300 |
| DOI: | 10.1016/S1556-0864(16)30010-7 |
| Notes: | Meeting Abstract: ORAL33.03 -- Source: Wos |
